Evaluate the effectiveness of an investigational medication for the treatment of adolescent fibromyalgia.

Duration:

10 Months

Number of visits:

16 visits

Compensation:

$50 per visit Up to $800

Qualifications and Notes:

13-17 years old; Individuals diagnosed with Juvenile Primary Fibromyalgia Syndrome.

Evaluate the safety and effectiveness of Ragweed Allergy immunotherapy tablet in adults

Duration:

11 weeks

Number of visits:

3 visits

Compensation:

$50 per visit Up to $150

Qualifications and Notes:

Notes: 18 years or older; must have been diagnosed with Ragweed Allergy for at least 2 years.

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Pain due to recent onset Supraspinatous Subacromial Tendonitits and/or Subdeltoid Bursitis of the Shoulder

Duration:

weeks

Number of visits:

3 visits

Compensation:

Visits  $; Visits  $

Qualifications and Notes:

Male or female 18 and older.

To evaluate and compare an investigational capsule to an already approved capsule or a placebo (sugar pill).

Duration:

4-5 weeks

Number of visits: 

5 visits

Compensation:

Visits 1-2 $25; Visits 3-5 $45

Qualifications and Notes: 

Male or female 18 and older; unknown constipation; 2 or less bowel movements per week.

We currently have 4 different studies for individuals with Chronic Obstructive Pulmonary Disease (COPD).

Compensation is provided for time and travel.

To evaluate the effectiveness of Lixisenatide in preventing cardiovascular events (heart attack like myocardial infarction) by lowering the blood sugar in subjects with Type-2 Diabetes.

Duration:

14 to 54 months, depends when you start the study

Number of visits:

24 visits

Compensation:

Up to $1200

Qualifications and Notes:

This study is for people who have both diabetes and heart disease, AND who have recently been in the hospital for a cardiovascular event such as heart attack or unstable angina.

Are you eligible?

You may be eligible for the ELIXA study if you:

• Are over 30 years old
• Have type 2 diabetes or have been told you have a high blood sugar level
• Were recently in the hospital for a heart-related problem (for example, a heart attack or unstable angina)

and see if you qualify for the ELIXA study

To evaluate an investigational drug intended to be taken with your current antidepressant (SSRI), to see if it helps to lessen any ongoing symptoms of depression. Coverage for your current prescription antidepressant will be provided.

Duration:

14 weeks

Number of visits:

14 visits

Compensation:

$50.00 per visit

Qualifications and Notes:

A diagnosis of major depressive disorder; Needs to be stable for at least one month on an antidepressant.

Study the effects of Allopurinol as the standard of care treatment for gout.

Duration:

6 Months of Treatment

Number of visits:

8 or 9 visits

Compensation:

$50.00 for completed visit

Qualifications and Notes:

Patients 18 to 85 who have Gout and have experienced at least (2) Gout Flares in the last 12 months.

To compare the risk of predefined major cardiovascular adverse events (MACE) during treatment with Febuxostat and Allopurinol in subjects with gout and Cardiovascular risks.

Duration:

Approximately 5 years

Number of visits:

Patients will be seen every (2) weeks for the first (10) weeks depending on serum uric acid levels.
Subject will be seen at least every three months for twelve months.
then every (6) months until the study ends.

Compensation:

$50 for each visit.

Qualifications and Notes:

Males over 50 years of age. Females over 55 years and had at least 2-years post-menopausal with gout and a prior history of major cardiovascular event such as heart attack, stroke or angina.